0589/2016 - Use of trigger tools for searching adverse drug reactions that cause emergency department admission in elderly population
Uso de rastreadores para busca de reações adversas a medicamentos como motivo de admissão de idosos em pronto-socorro
Author:
• Kelly Lie Nagai - Nagai, Kelly Lie - São Paulo, São Paulo - Universidade de Sao Paulo, Faculdade de Saúde Púlbica - <kellylie17@gmail.com>Co-author(s):
• Patricia Sayuri Katayose Takahashi - Takahashi , Patricia Sayuri Katayose - Universidade de Sao Paulo Hospital Universitario de Sao Paulo, Pharmacy - <patricsk@gmail.com>• Lucia Mendes de Oliveira Pinto - Pinto, Lucia Mendes de Oliveira - Universidade de Sao Paulo, Hospital Universitário - <luciamop@terra.com.br>
• Nicolina Silvana Romano-lieber - Romano-lieber, Nicolina Silvana - Universidade de São Paulo (USP), Prática de Saúde Pública (HSP) - <nicolina@usp.br>
Thematic Area:
Saúde do IdosoAbstract:
Adverse drug reactions may be the cause of illnesses, disability or death,especially in elderly patients. An active search of adverse drug reaction
suspicions that motivated elderly patients to look for care in the
emergency room was conducted with the use of trigger tools. It was a
transversal and retrospective study that used an adaptation of the
Institute of Healthcare Improvement’s trigger tools. In the analysis of 287
medical records, 38 triggers were found, of which 7 identified suspicious
adverse drug reactions. One was identified without a trigger. In total, 8
reactions were found (2,79%). The most implicated drugs were that for the
alimentary tract and metabolism, and for the cardiovascular system. Of the
tested triggers, some are essential for use in the emergency room, such as
those which indicate problems with anticoagulants, anti-hypertensives and
hypoglycemic agents, drugs widely used by elderly people. Others are
suitable for prospective studies, as they require detailed assessment to
confirm the suspicion of adverse reactions. The triggers should be tailored
to each institution, but were useful for the detection of suspected adverse
reactions, identifying problems occurring outside the hospital setting and
signaling drugs involving greater risk to the elderly.